IGC · Company research
IGC Pharma, Inc. (IGC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| An AI tool aims to turn Alzheimer's risk predictions into ongoing brain-health tracking. - Stock Titan | An AI tool aims to turn Alzheimer's risk predictions into ongoing brain-health tracking. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| IGC Pharma (IGC) Ticks Up to $0.28 as Shares Press Against Short-Term Resistance - Institutional Flow Picks - https://www.siam.in/ | IGC Pharma (IGC) Ticks Up to $0.28 as Shares Press Against Short-Term Resistance - Institutional Flow Picks https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 4, 2026 | neutral | 0 | 0.6 |
| Each of two children received 100,000 shares as gifts from IGC Pharma (IGC) CEO Ram Mukunda. - Stock Titan | Each of two children received 100,000 shares as gifts from IGC Pharma (IGC) CEO Ram Mukunda. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| 168 people are enrolled in a trial for Alzheimer's-related agitation. Results are expected in 2026's final quarter. - Stock Titan | 168 people are enrolled in a trial for Alzheimer's-related agitation. Results are expected in 2026's final quarter. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| IGC Pharma earnings matched, revenue fell short of estimates - Investing.com | IGC Pharma earnings matched, revenue fell short of estimates Investing.com | View source ↗ | Investing.com | Aug 18, 2026 | neutral | 0 | 0.6 |
| IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign - Yahoo Finance | IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign Yahoo Finance | View source ↗ | Yahoo Finance | Jul 29, 2026 | neutral | 0 | 0.6 |
| IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company - Yahoo Finance | IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company Yahoo Finance | View source ↗ | Yahoo Finance | Jul 7, 2026 | neutral | 0 | 0.6 |
| Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates - FinancialContent | Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates FinancialContent | View source ↗ | FinancialContent | Jun 30, 2026 | neutral | 0 | 0.6 |
| IGC Forecast — Price Target — Prediction for 2027 - TradingView | IGC Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts - Yahoo Finance | Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts Yahoo Finance | View source ↗ | Yahoo Finance | Jun 9, 2026 | neutral | 0 | 0.6 |
| IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment - BioSpace | IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment BioSpace | View source ↗ | BioSpace | May 20, 2026 | neutral | 0 | 0.6 |
| TLRY, CGC, IGC Stocks Light Up On Trump Pot Reclassification Hopes This Week - Stocktwits | TLRY, CGC, IGC Stocks Light Up On Trump Pot Reclassification Hopes This Week Stocktwits | View source ↗ | Stocktwits | Apr 22, 2026 | neutral | 0 | 0.6 |
| Would You Still Hold IGC Pharma Stock If It Fell Another 30%? - Trefis | Would You Still Hold IGC Pharma Stock If It Fell Another 30%? Trefis | View source ↗ | Trefis | Dec 20, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 26, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.